These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20940117)

  • 1. [Data on secondary prevention of coronary artery disease in Hungary and some changes in the last ten years (EUROASPIRE 1995-2005)].
    Jánosi A; Ostör E; Borbás S; Kazinczy R; Káli A; Vámos I; Bradák A; Podmaniczky M
    Orv Hetil; 2010 Oct; 151(43):1776-82. PubMed ID: 20940117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary prevention of coronary disease--at the turn of the millennium in light of the Hungarian data of the EUROASPIRE I-II. Studies].
    Ostör E; Jánosi A; Adám Z; Bárczy G; Borbás S; Dávid B; Gallai I; Podmaniczky M; Ruzsányi T
    Orv Hetil; 2003 Dec; 144(49):2399-404. PubMed ID: 14725205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
    Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
    Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Lancet; 2009 Mar; 373(9667):929-40. PubMed ID: 19286092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EUROASPIRE: survey conducted by the European Society of Cardiology on secondary prevention of coronary disease. Hungarian results].
    Ostör E; Jánosi A; Belatiny KA; Borbás S; Bradak A; Podmaniczky M
    Orv Hetil; 1999 Jan; 140(5):243-8. PubMed ID: 10064978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
    Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [EUROASPIRE-IV: European Society of Cardiology study of lifestyle, risk factors, and treatment approaches in patients with coronary artery disease: Data from Turkey].
    Tokgözoğlu L; Kayıkçıoğlu M; Altay S; Aydoğdu S; Barçın C; Bostan C; Çakmak HA; Çatakoğlu AB; Emet S; Ergene O; Kalkan AK; Kaya B; Tulunay Kaya C; Kaymaz C; Koylan N; Kültürsay H; Oğuz A; Özpelit E; Ünlü S
    Turk Kardiyol Dern Ars; 2017 Mar; 45(2):134-144. PubMed ID: 28424435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
    EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
    Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
    EUROASPIRE II Study Group
    Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
    Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.
    Kotseva K; De Bacquer D; Jennings C; Gyberg V; De Backer G; Rydén L; Amouyel P; Bruthans J; Cifkova R; Deckers JW; De Sutter J; Fraz Z; Graham I; Keber I; Lehto S; Moore D; Pajak A; Wood D;
    Glob Heart; 2017 Dec; 12(4):315-322.e3. PubMed ID: 26994643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.
    Kumbhani DJ; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Deedwania P; Grau-Sepulveda M; Schwamm LH; Bhatt DL;
    Am J Med; 2015 Apr; 128(4):426.e1-9. PubMed ID: 25433302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe.
    Vranckx P; Boersma E; Garg S; Valgimigli M; Van Es GA; Goedhart D; Serruys PW
    EuroIntervention; 2011 Nov; 7(7):859-71. PubMed ID: 22082582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of coronary artery disease in Kyrgyzstan: a comparison with Turkey and europe according to European Action on Primary and secondary prevention by intervention to reduce events III results.
    Kutlu R; Muratalievic TM; Memetoglu ME
    Turk Kardiyol Dern Ars; 2014 Sep; 42(6):545-52. PubMed ID: 25362945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment potential for dyslipidaemia management in patients with coronary heart disease across Europe: findings from the EUROASPIRE III survey.
    Reiner Ž; De Bacquer D; Kotseva K; Prugger C; De Backer G; Wood D;
    Atherosclerosis; 2013 Dec; 231(2):300-7. PubMed ID: 24267243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle and risk factor management in people at high cardiovascular risk from Bulgaria, Croatia, Poland, Romania and the United Kingdom who participated in both the EUROASPIRE III and IV primary care surveys.
    De Backer G; De Bacquer D; Rydén L; Kotseva K; Gaita D; Georgiev B; Gotcheva N; Mancas S; Miličić D; Pająk A; Reiner Ž; Wood D;
    Eur J Prev Cardiol; 2016 Oct; 23(15):1618-27. PubMed ID: 27084894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study.
    Vedin O; Hagström E; Stewart R; Brown R; Krug-Gourley S; Davies R; Wallentin L; White H; Held C
    Eur J Prev Cardiol; 2013 Aug; 20(4):678-85. PubMed ID: 22496275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey.
    Heuschmann PU; Kircher J; Nowe T; Dittrich R; Reiner Z; Cifkova R; Malojcic B; Mayer O; Bruthans J; Wloch-Kopec D; Prugger C; Heidrich J; Keil U
    Eur J Prev Cardiol; 2015 Oct; 22(10):1354-62. PubMed ID: 25139770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated risk profile of women in secondary prevention of coronary artery disease: a 6-year survey of 117,913 patients.
    Reibis RK; Bestehorn K; Pittrow D; Jannowitz C; Wegscheider K; Völler H
    J Womens Health (Larchmt); 2009 Aug; 18(8):1123-31. PubMed ID: 19630543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary prevention in patients after hospitalisation due to coronary artery disease: what has changed since 2006?
    Jankowski P; Czarnecka D; Lysek R; Skrzek A; Smaś-Suska M; Mazurek A; Brzozowska-Kiszka M; Wolfshaut-Wolak R; Surowiec S; Bogacki P; Bryniarska-Mirek E; Bryniarski L; Grodecki J; Nessler J; Olszowska M; Podolec P; Kawecka-Jaszcz K; Pająk A
    Kardiol Pol; 2014; 72(4):355-62. PubMed ID: 24408064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.